Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Boon

Showing results (121-130 of 224) with videos related to

Pageof 23
Sort By:
Cancer Research|September 15, 2000
Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II moleculesR Chiari, G Hames, V Stroobant, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Cytolytic response of human T cells against allogeneic small cell lung carcinoma treated with interferon gammaP Weynants, P Wauters, P G Coulie, et al.
Immunogenetics|January 1, 1987
Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assayT Wölfel, A Van Pel, E De Plaen, et al.
The Journal of Experimental Medicine|September 1, 1995
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanomaB Van den Eynde, O Peeters, O De Backer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1995
A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanomaP G Coulie, F Lehmann, B Lethé, et al.
Infection|January 1, 1992
Open, randomized comparison of pefloxacin and cefotaxime in the treatment of complicated urinary tract infectionsC Timmerman, I Hoepelman, J de Hond, et al.
Annals of the New York Academy of Sciences|December 30, 1991
Tum- antigens, TSTA, and T cell immune surveillanceA Van Pel, G Warnier, B Van den Eynde, et al.
International Journal of Cancer|January 21, 1992
Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cellsP G Coulie, M Somville, F Lehmann, et al.
Biochemical Society Transactions|August 1, 1995
Human tumour antigens recognized by T-cells: perspectives for new cancer vaccinesB Van den Eynde, B Gaugler, P van der Bruggen, et al.
Annual Review of Immunology|January 1, 1994
Tumor antigens recognized by T lymphocytesT Boon, J C Cerottini, B Van den Eynde, et al.
Pageof 23

Showing results (121-130 of 224) with videos related to

Sort By:
Pageof 23
Cancer Research|September 15, 2000
Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II moleculesR Chiari, G Hames, V Stroobant, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Cytolytic response of human T cells against allogeneic small cell lung carcinoma treated with interferon gammaP Weynants, P Wauters, P G Coulie, et al.
Immunogenetics|January 1, 1987
Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assayT Wölfel, A Van Pel, E De Plaen, et al.
The Journal of Experimental Medicine|September 1, 1995
A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanomaB Van den Eynde, O Peeters, O De Backer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1995
A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanomaP G Coulie, F Lehmann, B Lethé, et al.
Infection|January 1, 1992
Open, randomized comparison of pefloxacin and cefotaxime in the treatment of complicated urinary tract infectionsC Timmerman, I Hoepelman, J de Hond, et al.
Annals of the New York Academy of Sciences|December 30, 1991
Tum- antigens, TSTA, and T cell immune surveillanceA Van Pel, G Warnier, B Van den Eynde, et al.
International Journal of Cancer|January 21, 1992
Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cellsP G Coulie, M Somville, F Lehmann, et al.
Biochemical Society Transactions|August 1, 1995
Human tumour antigens recognized by T-cells: perspectives for new cancer vaccinesB Van den Eynde, B Gaugler, P van der Bruggen, et al.
Annual Review of Immunology|January 1, 1994
Tumor antigens recognized by T lymphocytesT Boon, J C Cerottini, B Van den Eynde, et al.
Pageof 23